Severe Hypoglycemia and Risks of Vascular Events and Death

Severe Hypoglycemia and Risks of Vascular Events and Death

Bibliographic Details
Main Authors:	Zoungas, S, Patel, A, Chalmers, J, de Galan, B, Li, Q, Billot, L, Woodward, M, Ninomiya, T, Neal, B, MacMahon, S, Grobbee, D, Kengne, A, Marre, M, Heller, S
Format:	Journal article
Published:	2010

Similar Items

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
by: Zoungas, S, et al.
Published: (2012)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2019)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
by: Blomster, J, et al.
Published: (2017)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
by: Patel, A, et al.
Published: (2008)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009)

Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009)

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes
by: Mohammedi, K, et al.
Published: (2016)

Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial
by: Arima, H, et al.
Published: (2011)

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
by: Arima, H, et al.
Published: (2010)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
by: Hata, J, et al.
Published: (2012)

Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
by: Campbell, D, et al.
Published: (2006)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
by: Czernichow, S, et al.
Published: (2011)

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
by: Ninomiya, T, et al.
Published: (2013)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
by: Patel, A, et al.
Published: (2007)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
by: Turnbull, F, et al.
Published: (2008)

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
by: Berthet, K, et al.
Published: (2004)

Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.
by: Campbell, D, et al.
Published: (2007)

Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
by: Campbell, D, et al.
Published: (2005)

Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
by: Campbell, D, et al.
Published: (2007)

Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
by: Campbell, D, et al.
Published: (2005)

Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.
by: Lewington, S, et al.
Published: (1999)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
by: Perkovic, V, et al.
Published: (2013)

The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock
by: Kengne, A, et al.
Published: (2010)

Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial
by: Ninomiya, T, et al.
Published: (2008)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
by: Hata, J, et al.
Published: (2013)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
by: Arima, H, et al.
Published: (2010)

Associations of proinflammatory cytokines with the risk of recurrent stroke.
by: Welsh, P, et al.
Published: (2008)

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial.
by: Jun Hata, et al.
Published: (2013-01-01)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
by: Kengne, A, et al.
Published: (2009)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
by: Lv, J, et al.
Published: (2012)

The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
by: Prentice, C, et al.
Published: (1999)

Blood pressure, cholesterol, and common causes ol death: A review
by: Lewington, S, et al.
Published: (1999)

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
by: Turnbull, F, et al.
Published: (2010)

Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
by: Woodward, M, et al.
Published: (2005)

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
by: Neal, B, et al.
Published: (2000)

Does hypoglycemia cause cardiovascular events?
by: Sandeep Chopra, et al.
Published: (2012-01-01)

Hypoglycemia and Risk of Death in Critically Ill Patients
by: Norton, R
Published: (2012)

Hypoglycemia as a risk factor for sudden death
by: А. S. Pogorelova
Published: (2016-12-01)

Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors.
by: MacMahon, S, et al.
Published: (1997)